Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

1. Balar, A.V.
2. Galsky, M.D.
3. Rosenberg, J.E.
4. Powles, T.
5. Petrylak, D.P.
6. Bellmunt, J.
7. Loriot, Y.
8. Necchi, A.
9. Hoffman-Censits, J.
10. Perez-Gracia, J.L.
11. Dawson, N.A.
12. van der Heijden, M.S.
13. Dreicer, R.
14. Srinivas, S.
15. Retz, M.M.
16. Joseph, R.W.
17. Drakaki, A.
18. Vaishampayan, U.N.
19. Sridhar, S.S.
20. Quinn, D.I.
21. Durán, I.
22. Shaffer, D.R.
23. Eigl, B.J.
24. Grivas, P.D.
25. Yu, E.Y.
26. Li, S.
27. Kadel, E.E.
28. Boyd, Z.
29. Bourgon, R.
30. Hegde, P.S.
31. Mariathasan, S.
32. Thåström, A.
33. Abidoye, O.O.
34. Fine, G.D.
35. Bajorin, D.F.
36. Mostrar todos los/as autores/as +